ResMed Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Michael J. Farrell
- Full Time Employees
- 10,600
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 9001 Spectrum Center Boulevard San Diego CA United States of America 92123
- IPO Date
- Jun 2, 1995
- CIK
- 0000943819
- Website
- resmed.com
- Similar Companies
- Business
- ResMed Inc. (NYSE: RMD; ASX: RMD) develops, manufactures, distributes and markets cloud-connected medical devices, digital health technologies and software platforms that diagnose, treat and manage sleep-disordered breathing, chronic obstructive pulmonary disease (COPD), respiratory insufficiency and other chronic diseases. The company offers continuous positive airway pressure (CPAP) and automatic positive airway pressure (APAP) devices including the AirSense and Air11 series; masks and accessories such as the AirFit, AirTouch N30i and F30i fabric-based platforms; ventilators like the Lumis series for non-invasive support; humidifiers including HumidCare; portable options such as AirMini; and software solutions encompassing myAir for patient self-monitoring, AirView for remote clinician oversight, and SaaS platforms for out-of-hospital care providers including residential care management tools. It operates through two primary segments: Sleep and Respiratory Care, addressing obstructive sleep apnea, central sleep apnea, overlap syndrome, obesity hypoventilation and neuromuscular diseases; and Software as a Service (SaaS), supporting healthcare professionals with data-driven platforms. ResMed serves patients, clinicians, sleep labs, homecare providers and health systems in over 140 countries, with key growth markets in the United States, Canada, Latin America, Europe, China, South Korea, India, Brazil and Eastern Europe. Founded in 1989 by Dr. Peter Farrell in Sydney, Australia, to commercialize CPAP technology, the company is headquartered in San Diego, California, and employs approximately 10,600 people. Recent developments include the May 2025 acquisition of VirtuOx, a leading independent diagnostic testing facility for at-home sleep, respiratory and cardiac testing, which operates as a wholly owned subsidiary to streamline diagnostics, enhance virtual care coordination and expand into adjacent areas like insomnia; launches of new AirTouch F30i mask variants including the comfort edition in Australia and clear edition in the U.S.; strategic U.S. manufacturing and distribution expansion in Indianapolis; and a board leadership change with director Richard Sulpizio departing following the 2025 annual stockholders' meeting.
BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)
Baader Bank Aktiengesellschaft Trims Position in ResMed Inc. $RMD
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care
ResMed Analyst Backs Portfolio Reset
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
Top 50 High-Quality Dividend Growth Stocks For July 2026
ResMed to sell software business MatrixCare for $490 million
Frazier Healthcare Partners Announces Definitive Agreement to Acquire MatrixCare
Resmed Announces Agreement to Sell MatrixCare Business
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock?
Here's Why ResMed (RMD) is a Strong Growth Stock
ResMed (RMD) Upgraded to Buy: Here's Why
Wall Street Analysts Think ResMed (RMD) Could Surge 28.21%: Read This Before Placing a Bet
Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
ResMed: Fear-Driven Selloff Creates A Compelling Margin Of Safety Entry Point
This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More
Why ResMed (RMD) is a Top Growth Stock for the Long-Term